🇺🇸 FDA
Patent

US 10849936

Compositions and methods for C. difficile treatment

granted A61KA61K2035/115A61K31/43

Quick answer

US patent 10849936 (Compositions and methods for C. difficile treatment) held by Regents of the University of Minnesota expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2035/115, A61K31/43, A61K35/74, A61K38/14